One thing I have learned from this forum is that using insulin as a T2 is in a lot of ways MORE complicated than using insulin as a T1. Mainly because you never know, when you're trying to figure out "what did what", how much of any effect on BG you're seeing is your own pancreas kicking in some help. Makes it super hard to make any predictions or calculations when you can't zero that out, but you can't know how much it was either or whether it will do it again next time.
So I see now that a lot of T2s are really stuck between a rock and a hard place as far as that goes. It does seem like pharmaceutical researchers are so focused on getting new drugs out that lower BGs (by any means possible) that we are getting wave after wave of ill-thought-out medications. I'm all for there being more options on the market rather than less, because any one of these drugs that causes innumerable problems for one person may be just the ticket for another person. But it would be nice if we had some more solid, good-for-a-majority-of-people options that were coming out rather than these drugs that force you to choose between one bad consequence (high BGs if you don't take it) or another (side effects if you do take it!)